<DOC>
	<DOCNO>NCT00073658</DOCNO>
	<brief_summary>This study compare safety effectiveness two medication , citalopram ( Celexa® ) risperidone ( Risperdal® ) .</brief_summary>
	<brief_title>Treating Behavioral Disturbances Individuals With Dementia</brief_title>
	<detailed_description>Dementia-related behavioral disturbance associate excess disability , increase caregiver burden , premature institutionalization . Pharmacotherapy often necessary treat disturbance . This study use citalopram risperidone treat people dementia-related behavior problem . Participants study begin psychotropic medication washout period 3 day study start . Participants randomly assign receive either citalopram risperidone 12 week . Limited dos sedative lorazepam may administer need throughout study . During first 2 week study , participant admit hospital dementia-related behavioral disturbance stabilize . Following hospital discharge , participant move long-term care facility residential home continue medication treatment 10 week . Side effect improvements behavioral status assess every week Week 6 every 2 week thereafter . Experimental laboratory measure collect study start , Week 1 , Week 2 , every 2 week thereafter Week 12 . Upon study completion , patient may continue receive citalopram risperidone supervision current physician . Three month study completion , participant may contact follow-up report psychiatric medical status .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis Alzheimer 's type dementia and/or meet criterion probable possible Alzheimer 's disease Inpatient admittance Western Psychiatric Institute Clinic Written inform consent participant 's legally authorize representative participant 's assent Psychosis behavioral problem severe enough danger participant 's health , wellbeing , safety Score 3 6 ( moderate severe ) least one Neurobehavioral Rating Scale ( NBRS ) agitation psychosis item Ability participate study evaluation ingest oral medication Diagnosis unstable medical illness within last 12 month Kidney liver dysfunction Diagnosis delirium , substanceinduced persist dementia , vascular dementia Score 12 high Cornell Scale Depression Dementia , score great 3 depression item NBRS Diagnosis Parkinson 's disease neurological illness may affect cognitive function History schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specify , bipolar affective disorder Alcohol substance abuse dependence Receiving monoamine oxidase inhibitor within 15 day study Display behavior could endanger participant 's life live others Received fluoxetine within 4 week screen</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Alzheimer disease</keyword>
	<keyword>Aggression</keyword>
	<keyword>Delusions</keyword>
	<keyword>Paranoid behavior</keyword>
</DOC>